BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28645137)

  • 1. To take or not to take: the association between perceived addiction risk, expected analgesic response and likelihood of trying novel pain relievers in self-identified chronic pain patients.
    Tompkins DA; Huhn AS; Johnson PS; Smith MT; Strain EC; Edwards RR; Johnson MW
    Addiction; 2018 Jan; 113(1):67-79. PubMed ID: 28645137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk stratification of opioid misuse among patients with cancer pain using the SOAPP-SF.
    Koyyalagunta D; Bruera E; Aigner C; Nusrat H; Driver L; Novy D
    Pain Med; 2013 May; 14(5):667-75. PubMed ID: 23631401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting Risk for Opioid Misuse in Chronic Pain with a Single-Item Measure of Catastrophic Thinking.
    Lutz J; Gross R; Long D; Cox S
    J Am Board Fam Med; 2017; 30(6):828-831. PubMed ID: 29180559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant drug-related behavior observed during a 12-week open-label extension period of a study involving patients taking chronic opioid therapy for persistent pain and fentanyl buccal tablet or traditional short-acting opioid for breakthrough pain.
    Passik SD; Narayana A; Yang R
    Pain Med; 2014 Aug; 15(8):1365-72. PubMed ID: 24666664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription opioid abuse and misuse: gap between primary-care investigator assessment and actual extent of these behaviors among patients with chronic pain.
    Setnik B; Roland CL; Pixton GC; Sommerville KW
    Postgrad Med; 2017 Jan; 129(1):5-11. PubMed ID: 27782769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shortening the Screener and Opioid Assessment for Patients with Pain-Revised (SOAPP-R): A Proof-of-Principle Study for Customized Computer-Based Testing.
    Finkelman MD; Kulich RJ; Zacharoff KL; Smits N; Magnuson BE; Dong J; Butler SF
    Pain Med; 2015 Dec; 16(12):2344-56. PubMed ID: 26176496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated pain sensitivity in chronic pain patients at risk for opioid misuse.
    Edwards RR; Wasan AD; Michna E; Greenbaum S; Ross E; Jamison RN
    J Pain; 2011 Sep; 12(9):953-63. PubMed ID: 21680252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beliefs and attitudes about opioid prescribing and chronic pain management: survey of primary care providers.
    Jamison RN; Sheehan KA; Scanlan E; Matthews M; Ross EL
    J Opioid Manag; 2014; 10(6):375-82. PubMed ID: 25531955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 2: special populations.
    Kahan M; Wilson L; Mailis-Gagnon A; Srivastava A;
    Can Fam Physician; 2011 Nov; 57(11):1269-76, e419-28. PubMed ID: 22084456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost of pain medication to treat adult patients with nonmalignant chronic pain in the United States.
    Rasu RS; Vouthy K; Crowl AN; Stegeman AE; Fikru B; Bawa WA; Knell ME
    J Manag Care Spec Pharm; 2014 Sep; 20(9):921-8. PubMed ID: 25166291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal preference in individuals reporting chronic pain: discounting of delayed pain-related and monetary outcomes.
    Tompkins DA; Johnson PS; Smith MT; Strain EC; Edwards RR; Johnson MW
    Pain; 2016 Aug; 157(8):1724-1732. PubMed ID: 27075431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impulsivity and risk for prescription opioid misuse in a chronic pain patient sample.
    Vest N; Reynolds CJ; Tragesser SL
    Addict Behav; 2016 Sep; 60():184-90. PubMed ID: 27156219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Short-Form Versions of the Screener and Opioid Assessment for Patients with Pain-Revised (SOAPP-R): A Proof-of-Principle Study.
    Finkelman MD; Smits N; Kulich RJ; Zacharoff KL; Magnuson BE; Chang H; Dong J; Butler SF
    Pain Med; 2017 Jul; 18(7):1292-1302. PubMed ID: 27605589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detecting aberrant opioid behavior in the emergency department: a prospective study using the screener and Opioid Assessment for Patients with Pain-Revised (SOAPP
    Varney SM; Perez CA; AraƱa AA; Carey KR; Ganem VJ; Zarzabal LA; Ramos RG; Bebarta VS
    Intern Emerg Med; 2018 Dec; 13(8):1239-1247. PubMed ID: 29502329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R).
    Butler SF; Fernandez K; Benoit C; Budman SH; Jamison RN
    J Pain; 2008 Apr; 9(4):360-72. PubMed ID: 18203666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk for Opioid Misuse Among Emergency Department Cancer Patients.
    Reyes-Gibby CC; Anderson KO; Todd KH
    Acad Emerg Med; 2016 Feb; 23(2):151-8. PubMed ID: 26824227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review to determine which validated measurement tools can be used to assess risk of problematic analgesic use in patients with chronic pain.
    Lawrence R; Mogford D; Colvin L
    Br J Anaesth; 2017 Dec; 119(6):1092-1109. PubMed ID: 28981581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Contribution of Differential Opioid Responsiveness to Identification of Opioid Risk in Chronic Pain Patients.
    Bruehl S; Burns JW; Passik SD; Gupta R; Buvanendran A; Chont M; Schuster E; Orlowska D; France CR
    J Pain; 2015 Jul; 16(7):666-75. PubMed ID: 25892658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do pain patients at high risk for substance misuse experience more pain? A longitudinal outcomes study.
    Jamison RN; Link CL; Marceau LD
    Pain Med; 2009 Sep; 10(6):1084-94. PubMed ID: 19671087
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.